En multivariatanalyse viste, at clofarabins farmakokinetik er vægtafhængig, og selvom det fremgik, at leukocyttallet påvirker clofarabins farmakokinetik, syntes dette ikke at være tilstrækkeligt til at fastsætte den enkelt patients behandlingsregime ud fra vedkommendes leukocyttal.
Multivariate analysis showed that the pharmacokinetics of clofarabine are weight dependent and although white blood cell (WBC) count was identified as having an impact on clofarabine pharmacokinetics, this did not appear sufficient to individualise a patient’ s dosage regimen based on their WBC count.